Journal
THEORETICAL FOUNDATIONS OF CHEMICAL ENGINEERING
Volume 50, Issue 6, Pages 895-900Publisher
MAIK NAUKA/INTERPERIODICA/SPRINGER
DOI: 10.1134/S0040579516060117
Keywords
mesenchymal stem cells; bioreactors; microcarriers; growth; suspension; detachment
Categories
Ask authors/readers for more resources
The use of human mesenchymal stem cells (hMSCs) in regenerative medicine is a potential major advance for the treatment of many medical conditions, especially with the use of allogeneic therapies where the cells from a single donor can be used to treat ailments in many patients. Such cells must be grown attached to surfaces and for large scale production, it is shown that stirred bioreactors containing similar to 200 mu m particles (microcarriers) can provide such a surface. It is also shown that the just suspended condition, agitator speed N (JS), provides a satisfactory condition for cell growth by minimizing the specific energy dissipation rate, epsilon(T), in the bioreactor whilst still meeting the oxygen demand of the cells. For the cells to be used for therapeutic purposes, they must be detached from the microcarriers before being cryopreserved. A strategy based on a short period (similar to 7 min) of very high epsilon(T), based on theories of secondary nucleation, is effective at removing > 99% cells. Once removed, the cells are smaller than the Kolmogorov scale of turbulence and hence not damaged. This approach is shown to be successful for culture and detachment in 4 types of stirred bioreactors from 15 mL to 5 L.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available